Royal Bank of Canada (RY) Announces Quarterly Dividend of $0.63

Royal Bank of Canada (TSE:RY) announced a quarterly dividend on Thursday, May 30th, AnalystRatingsNetwork.com reports. Stockholders of record on Thursday, July 25th will be paid a dividend of $0.63 per share on Friday, August 23rd. This represents a $2.52 annualized dividend and a dividend yield of 3.94%.

RY has been the subject of a number of recent research reports. Analysts at CIBC raised their price target on shares of Royal Bank of Canada from C$64.00 to C$70.00 in a research note to investors on Monday, March 4th. They now have a “sector outperform” rating on the stock. On a related note, analysts at Scotiabank reiterated a “sector outperform” rating on shares of Royal Bank of Canada in a research note to investors on Friday, March 1st. Finally, analysts at TD Securities raised their price target on shares of Royal Bank of Canada from C$63.00 to C$65.00 in a research note to investors on Friday, March 1st. They now have a “hold” rating on the stock.

Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of C$66.83.

Royal Bank of Canada (TSE: RY) opened at 63.98 on Thursday. Royal Bank of Canada has a 52-week low of $48.70 and a 52-week high of $64.92. The stock’s 50-day moving average is currently $61.36. The company has a market cap of $92.524 billion and a price-to-earnings ratio of 12.52.

Royal Bank of Canada (TSE: RY) is a diversified financial services company.

Latest News

UnitedHealth Group  Price Target Increased to $300.00 by Analysts at BMO Capital Markets
UnitedHealth Group Price Target Increased to $300.00 by Analysts at BMO Capital Markets
VICI Properties  Lifted to “Buy” at Zacks Investment Research
VICI Properties Lifted to “Buy” at Zacks Investment Research
TJX Companies  Stock Rating Upgraded by ValuEngine
TJX Companies Stock Rating Upgraded by ValuEngine
TransDigm Group  Upgraded by ValuEngine to “Buy”
TransDigm Group Upgraded by ValuEngine to “Buy”
Castlight Health Inc  Given Average Recommendation of “Hold” by Analysts
Castlight Health Inc Given Average Recommendation of “Hold” by Analysts
Relx  Earning Favorable News Coverage, Report Shows
Relx Earning Favorable News Coverage, Report Shows


© 2006-2018 Ticker Report. Google+.